OptimizeRx gets $3.5 million from preferreds sale

By Devika Patel

Knoxville, Tenn., Oct. 20 - OptimizeRx Corp. said it completed a $3.5 million financing.

The financing was structured as preferred shares that are convertible into common shares.

The investor also received warrants in the deal.

The financing was placed by Midtown Partners & Co., LLC.

Proceeds will be used to further support the company's growth plans of www.OptimizeRx.com and to accelerate the rollout of its marketing platforms, including the recently introduced OffeRx and the soon to be launched AdheRxE platforms.

Based in Rochester, Mich., OptimizeRx provides platforms to help patients better afford and comply to their medicines and health-care products, while offering pharmaceutical and health-care companies ways to expand patient awareness, access and adherence to their brands.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.